19500 Federal Register / Vol. 63, No. 75 / Monday, April 20, 1998 / Notices

TRANSACTION GRANTED EARLY TERMINATION—Continued

ET date Trans. No. ET req status Party name

G E.W. Richardson.

G Pioneer Ford Sales Inc.

FOR FURTHER INFORMATION CONTACT:

Sandra M. Peay or Parcellena P.

Fielding, Contact Representatives,

Federal Trade Commission, Premerger

Notification Office, Bureau of

Competition, Room 303, Washington,

D.C. 20580, (202) 326–3100.

By Direction of the Commission.

Donald S. Clark,

Secretary.

[FR Doc. 98–10392 Filed 4–17–98; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Notice of a Meeting of the National

Bioethics Advisory Commission

(NBAC)

SUMMARY: Pursuant to Section 10(d) of

the Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is given of a meeting of the National

Bioethics Advisory Commission. The

Commission will continue addressing

(1) the protection of the rights and

welfare of human subjects in research

including research involving persons

with disorders affecting decisionmaking

capacity, and (2) issues in the research

use of human biological materials. The

meeting is open to the public and

opportunities for statements by the

public will be provided on May 19,

1998 from 11:30 am to 12 Noon.

Dates/times Location

May 19, 1998, 8:30

am–5 pm and May

20, 1998, 8 am—3

pm.

Excelsior BallroomThwing Student

Center, Case Western Reserve University, 11111 Euclid Avenue, Cleveland, Ohio.

SUPPLEMENTARY INFORMATION: The

President established the National

Bioethics Advisory Commission (NBAC)

on October 3, 1995 by Executive Order

12975 as amended. The mission of the

NBAC is to advise and make

recommendations to the National

Science and Technology Council, its

Chair, the President and other entities

on bioethical issues arising from the

research on human biology and

behavior, and from the applications of

that research and makes its

recommendations available to the

public.

Public Participation

The meeting is open to the public

with attendance limited by the

availability of space on a first come, first

serve basis. Members of the public who

wish to present oral statements should

contact Ms. Patricia Norris by

telephone, fax machine, or mail as

shown below at least 4 days before the

meeting and as soon as possible. The

Chair will reserve time for presentations

by persons requesting to speak. The

order of persons wanting to make a

statement will be assigned on a first

come, first serve basis. Individuals

unable to make oral presentations can

mail or fax their comments to the NBAC

staff office at least five business days

prior to the meeting for distribution to

the Commission and inclusion in the

public record. The Commission also

accepts general comments at its website

at bioethics.gov. Persons needing

special assistance, such as sign language

interpretation or other special

accommodations, should contact NBAC

staff at the address or telephone number

listed below as soon as possible.

FOR FURTHER INFORMATION CONTACT: Ms.

Patricia Norris, National Bioethics

Advisory Commission, 6100 Executive

Boulevard, Suite 5B01, Rockville,

Maryland 20892–7508, telephone 301–

402–4242, fax number 301–480–6900.

Henrietta D. Hyatt-Knorr,

Deputy Executive Director, National Bioethics

Advisory Commission.

[FR Doc. 98–10386 Filed 4–17–98; 8:45 am]

BILLING CODE 4160–17–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Board of Scientific Counselors,

National Institute for Occupational

Safety and Health Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting:

Name: Board of Scientific Counselors,

National Institute for Occupational Safety

and Health (BSC, NIOSH).

Time and Date: 9 a.m.–4 p.m., May 20,

1998.

Place: The Washington Court, Montpelier

Room, 525 New Jersey Avenue, NW,

Washington, DC 20001–1527.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 50 people.

Purpose: The BSC, NIOSH is charged with

providing advice to the Director, NIOSH on

NIOSH research programs.

Specifically, the Board shall provide

guidance on the Institute’s research activities

related to developing and evaluating

hypotheses, systematically documenting

findings, and disseminating results.

Matters to be Discussed: Agenda items

include a report from the Director of NIOSH;

Update on Latex Allergy Activities; Hearing

Loss Prevention Program; Hearing Loss

Communications Campaign; Update on

NIOSH Agriculture Program; State

Surveillance Planning Update; Evaluating

NIOSH Small Business Interventions; and

future activities of the Board.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information: Dr.

Bryan D. Hardin, Executive Secretary, BSC,

NIOSH, 1600 Clifton Road, NE, m/s D–35,

Atlanta, Georgia 30333. Telephone 404/639–

3773, fax 404/639–2170, e-mail

bdh1@cdc.gov.

Dated: April 13, 1998.

Nancy C. Hirsch,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–10296 Filed 4–17–98; 8:45 am]

BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Submission for OMB Review;

Comment Request

Title: Summary Date Component

(SDC) of the National Child Abuse and

Neglect Data System (NCANDS).

OMB No.: 0980–0229.

Description: This information

collection implements the provision of

the Child Abuse Prevention and

Treatment Act (42 U.S.C. 5101 et seq.),

as amended by Pub. L. 104–235,

requiring that State agencies receiving

the State child abuse and neglect grant
Federal Register / Vol. 63, No. 75 / Monday, April 20, 1998 / Notices 19501

annually provide, ‘‘to the maximum

extent practical,’’ an annual data report.

Data elements include the number of

children reported for child abuse and

neglect; the number of children for

whom maltreatment was substantiated,

unsubstantiated or determined to be

false; the number of deaths resulting

from child abuse or neglect; the number

of children who received services;

agency response times; and the number

of workers responsible for child

protective service (CPS) functions. The

new annual State data report is being

combined with the previously existing

voluntary Summary Data Component of

the National Child Abuse and Neglect

Data System. The information collected

will be used to understand better the

experiences of children and families

served by CPS agencies, and to help

guide policy and program development

at the National, State and local levels.

Respondents: State, Local or Tribal

Govt.

ANNUAL BURDEN ESTIMATES

Instrument Number of respondents

Number of responses per

respondent

Average burden hours per

response

Total burden

hours

SDC .................................................................................................................. 56 1 60 3,360

Estimated Total Annual Burden Hours: 3,360.

Additional Information: Copies of the

proposed collection may be obtained by

writing to The Administration for

Children and Families, Office of

Information Services, 370 L’Enfant

Promenade, S.W., Washington, D.C.

20447, Attn: ACF Reports Clearance

Officer.

OMB Comment: OMB is required to

make a decision concerning the

collection of information between 30

and 60 days after publication of this

document in the Federal Register.

Therefore, a comment is best assured of

having its full effect if OMB receives it

within 30 days of publication. Written

comments and recommendations for the

proposed information collection should

be sent directly to the following: Office

of Management and Budget, Paperwork

Reduction Project, 725 17th Street,

N.W., Washington, D.C. 20503, Attn:

Ms. Laura Oliven.

Dated: April 13, 1998.

Bob Sargis,

Acting Reports Clearance Officer.

[FR Doc. 98–10256 Filed 4–17–98; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Antiviral Drugs Advisory Committee;

Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Antiviral Drugs

Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on FDA

regulatory issues.

Date and Time: The meeting will be

held on May 4, 1998, 8:30 a.m to 5 p.m.;

on May 5, 1998, 8 a.m. to 5 p.m.; and

on May 6, 1998, 7:30 a.m. to 5 p.m.

Location: Gaithersburg Hilton,

Ballroom, 620 Perry Pkwy.,

Gaithersburg, MD.

Contact Person: Rhonda W. Stover or

John B. Schupp, Center for Drug

Evaluation and Research (HFD–21),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–443–5455, or FDA Advisory

Committee Information Line, 1–800–

741–8138 (301–443–0572 in the

Washington, DC area), code 12531.

Please call the Information Line for upto-date information on this meeting.

Agenda: On May 4, 1998, the

committee will discuss new drug

application (NDA) 20–903, IntronA/

Rebetol, (interferon alfa-2b,

recombinant/ribavirin, Schering Corp.)

for the treatment of chronic hepatitis C.

On May 5, 1998, the committee will

discuss NDA 50–752, Priftin

(rifapentine, Hoechst Marion Roussel,

Inc.) for the treatment of pulmonary

tuberculosis. On May 6, 1998, the

committee will discuss NDA 20–871,

NTZTM (nitazoxanide, UNIMED

Pharmaceuticals, Inc.) for the treatment

of diarrhea associated with

cryptosporidiosis in acquired immune

deficiency syndrome (AIDS) patients.

Procedure: On May 4, 1998, from 8:30

a.m. to 5 p.m.; on May 5, 1998, from 8

a.m. to 10:30 a.m. and from 12 m. to 5

p.m.; and on May 6, 1998, from 9 a.m.

to 5 p.m., the meeting is open to the

public. Interested persons may present

data, information, or views, orally or in

writing, on issues pending before the

committee. Written submissions may be

made to the contact person by April 27,

1998. Oral presentations from the public

will be scheduled between

approximately 11 a.m. and 12 m. on

May 4 and May 6, 1998. On May 5,

1998, oral presentations from the public

will be scheduled between

approximately 1 p.m. and 2 p.m. Time

allotted for each presentation may be

limited. Those desiring to make formal

oral presentations should notify the

contact person before April 27, 1998,

and submit a brief statement of the

general nature of the evidence or

arguments they wish to present, the

names and addresses of proposed

participants, and an indication of the

approximate time requested to make

their presentation.

Closed Committee Deliberations: On

May 5, 1998, from 10:30 a.m. to 12 m.,

the meeting will be closed for a

presentation of confidential material (5

U.S.C. 552(b)(2) and (b)(5)). On May 6,

1998, from 7:30 a.m. to 9 a.m., the

meeting will be closed to permit

discussion and review of trade secret

and/or confidential information (5

U.S.C. 552(b)(4)). The selected NDA’s

will be discussed.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: April 14, 1998.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 98–10311 Filed 4–17–98; 8:45 am]

BILLING CODE 4160–01–F